US Court dismisses whistleblower case against Millennium Labs

5 February 2012

US District Court Judge Joseph Tauro has ordered the complete dismissal of a whistleblower law suit against Millennium Laboratories, a US research-based medication monitoring company, brought by a former Calloway Laboratories' senior officer.

Although the Department of Justice had previously stated publicly - twice - that it was not intervening in the law suit, and consented to its dismissal in a January court filing, the case was nonetheless pursued for nearly a year as a civil matter by Calloway's proxy. By dismissing the case with prejudice, the Court barred any copy-cat lawsuits and the government's investigation of the case is now over.

"Millennium feels vindicated by the Judge's ruling that finally brings closure to an unfortunate distraction from our mission to improve the lives of those suffering from chronic pain," said Howard Appel, president of Millennium Laboratories.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical